Author

V. Mangipudi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. Li· 1 shared C. Lu· 1 shared D. Karagiannis· 1 shared F. J. Sanchez-Rivera· 1 shared J. Ye· 1 shared M. Hayashi· 1 shared M. Yip· 1 shared T. Papagiannakopoulos· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Li

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Metabolic Reprogramming by Histone Deacetylase Inhibition Selectively Targets NRF2-activated tumors.

D. Karagiannis, W. Wu, A. Li, M. Hayashi, X. Chen, M. Yip, V. Mangipudi, X. Xu, F. J. Sanchez-Rivera, Y. M. Soto-Feliciano, J. Ye, T. Papagiannakopoulos, C. Lu

The paper shows that inhibiting HDACs selectively targets NRF2-activated lung adenocarcinoma by altering chromatin and metabolic pathways.

bioRxiv · Apr 24, 2023 · PreprintCancer Biology